JNJ 10198409

Pricing Availability   Qty
Description: Potent PDGFRα and PDGFRβ inhibitor; also inhibits c-Abl, Lck, c-Src and Fyn kinases
Chemical Name: N-(3-Fluorophenyl)-1,4-dihydro-6,7-dimethoxyindeno[1,2-c]pyrazol-3-amine
Purity: ≥98% (HPLC)
Citations (8)
Protocols (1)
Literature (1)

Biological Activity for JNJ 10198409

JNJ 10198409 is a potent platelet-derived growth factor receptor (PDGFR) inhibitor (IC50 values are 4.2 and 45 nM for PDGFRβ and PDGFRα, respectively). Also inhibits c-Abl, Lck, c-Src and Fyn kinases (IC50 values are 22, 100, 185 and 378 nM respectively). Displays antiproliferative activity in multiple tumor cell lines. Accelerates down regulation of fibroblast genes in transdifferentiation of human fibroblasts into functional cardiomyocytes, within 9C cocktail.

For more information about how JNJ 10198409 may be used, see our protocol: Converting Fibroblasts into Cardiomyocytes (9C Cocktail)

Licensing Information

Sold with the permission of Janssen Pharmaceutica N.V.

Compound Libraries for JNJ 10198409

JNJ 10198409 is also offered as part of the Tocriscreen 2.0 Max, Tocriscreen Kinase Inhibitor Library, Tocriscreen Antiviral Library and Tocriscreen Stem Cell Library. Find out more about compound libraries available from Tocris.

Technical Data for JNJ 10198409

M. Wt 325.34
Formula C18H16FN3O2
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 627518-40-5
PubChem ID 9797370
Smiles COC1=C(OC)C=C2C(CC3=C2NN=C3NC2=CC(F)=CC=C2)=C1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for JNJ 10198409

Solvent Max Conc. mg/mL Max Conc. mM
DMSO 6.51 20
ethanol 32.53 100

Preparing Stock Solutions for JNJ 10198409

The following data is based on the product molecular weight 325.34. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 3.07 mL 15.37 mL 30.74 mL
5 mM 0.61 mL 3.07 mL 6.15 mL
10 mM 0.31 mL 1.54 mL 3.07 mL
50 mM 0.06 mL 0.31 mL 0.61 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

References for JNJ 10198409

References are publications that support the biological activity of the product.

Ho et al (2005) (6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamines: platelet-derived growth factor receptor tyrosine kinase inhibitors with broad antiproliferative activity against tumor cells. J.Med.Chem. 29 8163 PMID: 16366598

Cao et al (2016) Conversion of human fibroblasts into functional cardiomyocytes by small molecules. Science. 352 1216 PMID: 27127239

If you know of a relevant reference for JNJ 10198409, please let us know.

View Related Products by Product Action

View all PDGFR Inhibitors

Keywords: JNJ 10198409, JNJ 10198409 supplier, JNJ10198409, stem, cell, reprogramming, 9C, cocktail, cardiomyocytes, myocytes, platelet-derived, growth, factor, receptor, alpha, beta, inhibitors, inhibits, PDGFR, PDGFRb, PDGFRa, transdifferentiation, Src, Kinases, Other, Stem, Cell, Reprogramming, Cardiomyocyte, Cells, 6976, Tocris Bioscience

8 Citations for JNJ 10198409

Citations are publications that use Tocris products. Selected citations for JNJ 10198409 include:

Stewart O et al (2015) Conventional protein kinase C isoforms differentially regulate ADP- and thrombin-evoked Ca2+ signalling in human platelets. Cell Calcium 58 577-88 PMID: 26434503

Zhihui et al (2011) Mechanical regulation of glycogen synthase kinase 3β (GSK3β) in mesenchymal stem cells is dependent on Akt protein serine 473 phosphorylation via mTORC2 protein. J Biol Chem 286 39450-6 PMID: 21956113

Donghong et al (2020) Anaplastic Lymphoma Kinase Regulates Internalization of the Dopamine D2 Receptor. Mol Pharmacol 97 123-131 PMID: 31734646

F et al (2000) Protein kinase C activity modulates dendritic differentiation of rat Purkinje cells in cerebellar slice cultures. Eur J Neurosci 12 1993-2005 PMID: 10886339

Do you know of a great paper that uses JNJ 10198409 from Tocris? Please let us know.

Reviews for JNJ 10198409

There are currently no reviews for this product. Be the first to review JNJ 10198409 and earn rewards!

Have you used JNJ 10198409?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Protocols for JNJ 10198409

The following protocol features additional information for the use of JNJ 10198409 (Cat. No. 6976).

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

Angiogenesis in Cancer Poster

Angiogenesis in Cancer Poster

This poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.